SERPINA1 and alpha 1-antitrypsin deficiency: As a follow up to the above referred studies, we analyzed plasma levels of Z-AAT polymers in two independent retrospective cohorts of ZZ-AATD patients with lung and liver involvement, respectively, who did not receive AAT augmentation therapy.